Akari Therapeutics Plc Increase (Decrease) in Accounts Payable, Trade
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableTrade · last filed 2015-08-12
- Akari Therapeutics Plc increase (decrease) in accounts payable, trade for the quarter ending 2015-06-30 was $333.00K, a 22.01% decline year-over-year.
- Akari Therapeutics Plc increase (decrease) in accounts payable, trade for the quarter ending 2015-03-31 was -$707.00K, a 468.23% decline year-over-year.
- Akari Therapeutics Plc increase (decrease) in accounts payable, trade for the quarter ending 2014-06-30 was $427.00K.
- Akari Therapeutics Plc increase (decrease) in accounts payable, trade for the quarter ending 2014-03-31 was $192.00K.
- Akari Therapeutics Plc increase (decrease) in accounts payable, trade for fiscal 2014 was $351.00K.
- Akari Therapeutics Plc increase (decrease) in accounts payable, trade for fiscal 2013 was -$1.04M, a 266.67% decline from fiscal 2012.
- Akari Therapeutics Plc increase (decrease) in accounts payable, trade for fiscal 2012 was $627.00K.
| Period end | Increase (Decrease) in Accounts Payable, Trade 3 month | Increase (Decrease) in Accounts Payable, Trade 6 month | Increase (Decrease) in Accounts Payable, Trade 12 month | Increase (Decrease) in Accounts Payable, Trade 99 month | Increase (Decrease) in Accounts Payable, Trade 111 month |
|---|---|---|---|---|---|
| 2015-06-30 | $333.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | -$374.00K 10-Q · filed 2015-08-12 | |||
| 2015-03-31 | -$707.00K 10-Q · filed 2015-05-12 | ||||
| 2014-12-31 | $351.00K 10-K · filed 2015-02-11 | ||||
| 2014-06-30 | $427.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | $619.00K 10-Q · filed 2015-08-12 | |||
| 2014-03-31 | $192.00K 10-Q · filed 2015-05-12 | ||||
| 2013-12-31 | -$1.04M 10-K · filed 2015-02-11 | $965.00K 20-F · filed 2014-03-24 | |||
| 2012-12-31 | $627.00K 10-K · filed 2015-02-11 | $2.01M 20-F/A · filed 2013-04-19 | |||
| 2011-12-31 | $612.00K 20-F · filed 2014-03-24 | ||||
| 2010-12-31 | $237.00K 20-F/A · filed 2013-04-19 |